Anzeige
Mehr »
Samstag, 08.11.2025 - Börsentäglich über 12.000 News
Der Trump-Effekt: Kupfer wird kritisch. Vizsla schießt senkrecht!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C017 | ISIN: FR0010907956 | Ticker-Symbol: CXT
Lang & Schwarz
08.11.25 | 13:02
0,099 Euro
-100,00 % -0,099
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CARMAT Chart 1 Jahr
5-Tage-Chart
CARMAT 5-Tage-Chart
RealtimeGeldBriefZeit
0,0980,09913:02

Aktuelle News zur CARMAT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCARMAT Provides an Update on the Ongoing Receivership Procedure257A takeover bid within the context of a sales plan has been received by the judiciary administrator Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced...
► Artikel lesen
29.10.CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)254Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
CARMAT Aktie jetzt für 0€ handeln
15.10.CARMAT Provides an Update on the Ongoing Receivership Procedure234Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
01.10.CARMAT Provides an Update on the Ongoing Receivership Procedure229Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
29.09.CARMAT Provides an Update on the Ongoing Receivership Procedure365Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
25.09.XFRA CXT: AUSSETZUNG/SUSPENSION171DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARMAT EO -,04 CXT...
► Artikel lesen
24.09.CARMAT Provides an Update on the Ongoing Receivership Procedure282Trading of CARMAT shares suspended, starting September 25, 2025, before stock market opening, ahead of the court hearing scheduled on September 30, 2025 Regulatory News: CARMAT (FR0010907956...
► Artikel lesen
21.08.XFRA CXT: WIEDERAUFNAHME/RESUMPTION204FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
20.08.CARMAT Provides an Update on the Ongoing Receivership Procedure446Resumption of CARMAT shares trading starting on August 21, 2025, at stock market opening Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total...
► Artikel lesen
14.08.XFRA CXT: AUSSETZUNG/SUSPENSION183DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARMAT EO -,04 CXT...
► Artikel lesen
13.08.CARMAT Provides an Update on the Ongoing Receivership Procedure405Trading of CARMAT shares suspended, starting August 14, 2025, before stock market opening, ahead of the court hearing scheduled on August 19, 2025 Regulatory News: CARMAT (FR0010907956, ALCAR)...
► Artikel lesen
04.08.XFRA CXT: WIEDERAUFNAHME/RESUMPTION174FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
01.08.CARMAT Provides an Update on the Ongoing Receivership Procedure545One takeover bid within the context of a sales plan1 has been received by the judiciary administrator Resumption of CARMAT shares trading starting on August 4, 2025, at stock market opening...
► Artikel lesen
30.07.XFRA CXT: AUSSETZUNG/SUSPENSION215DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARMAT EO -,04 CXT...
► Artikel lesen
29.07.CARMAT Provides an Update on Its Situation and the Ongoing Receivership Procedure554Trading of CARMAT shares suspended, starting July 30, 2025, before stock market opening, ahead of the deadline of July 31, 2025 for submitting takeover or investment offers Regulatory News: CARMAT...
► Artikel lesen
28.07.PARIS - CARMAT's Aeson artificial heart receives MDR CE marking11
28.07.CARMAT Receives MDR CE Marking for Its Aeson Artificial Heart450Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
03.07.CARMAT Announces the Initiation of a Call for Public Tenders (Buyers or Investors) as Part of the Receivership Procedure585Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
02.07.XFRA CXT: WIEDERAUFNAHME/RESUMPTION291FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
01.07.Carmat files for insolvency12
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1